Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
Winship Cancer Institute, Emory University, Atlanta, Georgia University of Illinois at Chicago (UIC), Chicago, Illinois University of Chicago, Chicago, Illinois MD Anderson Cancer Center, Houston, Texas Huntsman Cancer Institute, Salt Lake City, Utah Last updated December 2025